These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21713234)

  • 1. Combined intravitreal bevacizumab with phacoemulsification in visually significant cataract and visually significant exudative maculopathy.
    Mansour A; Bashshur ZF; Sibai TA; Mehio-Sibai A; Hamam RN
    Oman J Ophthalmol; 2011 Jan; 4(1):10-6. PubMed ID: 21713234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phacoemulcification with intravitreal bevacizumab injection in patients with cataract and coexisting diabetic retinopathy: prospective randomized study.
    Salehi A; Beni AN; Razmjoo H; Beni ZN
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):212-8. PubMed ID: 22132722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery.
    Takamura Y; Kubo E; Akagi Y
    Ophthalmology; 2009 Jun; 116(6):1151-7. PubMed ID: 19376589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Effectiveness of Cataract Surgery with Simultaneous Intravitreal Anti-VEGF in Patients with Previously Treated Exudative Age-Related Macular Degeneration.
    Falcão MS; Freitas-Costa P; Beato JN; Pinheiro-Costa J; Rocha-Sousa A; Carneiro Â; Brandão EM; Falcão-Reis F
    Acta Med Port; 2017 Feb; 30(2):127-133. PubMed ID: 28527480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study.
    Cheema RA; Al-Mubarak MM; Amin YM; Cheema MA
    J Cataract Refract Surg; 2009 Jan; 35(1):18-25. PubMed ID: 19101420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of intravitreal bevacizumab and phacoemulsification surgery in patients with cataract and coexisting diabetic macular edema.
    Chen CH; Liu YC; Wu PC
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):83-9. PubMed ID: 19232012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.
    Habib MS; Cannon PS; Steel DH
    BMC Ophthalmol; 2005 Jun; 5():15. PubMed ID: 15972106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.
    Matos R; Beato J; Silva M; Silva S; Brandão E; Falcão-Reis F; Penas S
    Ophthalmic Genet; 2017; 38(5):490-493. PubMed ID: 28121209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract.
    Akinci A; Batman C; Ozkilic E; Altinsoy A
    Retina; 2009; 29(10):1432-5. PubMed ID: 19898181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity.
    Shah NV; Houston SK; Markoe AM; Feuer W; Murray TG
    Clin Ophthalmol; 2012; 6():1739-48. PubMed ID: 23152651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration.
    Furino C; Ferrara A; Cardascia N; Besozzi G; Alessio G; Sborgia L; Boscia F
    J Cataract Refract Surg; 2009 Sep; 35(9):1518-22. PubMed ID: 19683147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab combined with cataract surgery for treatment of exudative macular degeneration.
    Jonas JB; Spandau UH; Schlichtenbrede F; Libondi T; Vossmerbaeumer U; von Baltz S
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):599-600. PubMed ID: 18020962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after multiple intravitreal bevacizumab injections for exudative age-related macular degeneration.
    Tao Y; Libondi T; Jonas JB
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):79-83. PubMed ID: 20148662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and anatomic response of the retina and the choroid to intravitreal bevacizumab for macular edema.
    Forte R; Cennamo G; Breve MA; Vecchio EC; de Crecchio G
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):69-75. PubMed ID: 22059904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab combined with intravitreal triamcinolone for therapy-resistant exudative age-related macular degeneration.
    Tao Y; Jonas JB
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):207-12. PubMed ID: 20415625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.
    Iturralde D; Spaide RF; Meyerle CB; Klancnik JM; Yannuzzi LA; Fisher YL; Sorenson J; Slakter JS; Freund KB; Cooney M; Fine HF
    Retina; 2006 Mar; 26(3):279-84. PubMed ID: 16508427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.